| Bos taurus |
Serotonin 2a (5-HT2a) receptor |
IC50 |
610.0 |
nM |
10.1021/jm00114a018 |
| Cavia porcellus |
3-beta-hydroxysteroid-delta(8),delta(7)-isomerase |
Ki |
2.71 |
nM |
10.1021/jm021014d |
| Cavia porcellus |
3-beta-hydroxysteroid-delta(8),delta(7)-isomerase |
Ki |
4.7 |
nM |
10.1021/jm050654o |
| Cavia porcellus |
3-beta-hydroxysteroid-delta(8),delta(7)-isomerase |
Ki |
10.2 |
nM |
10.1021/jm9007505 |
| Cavia porcellus |
3-beta-hydroxysteroid-delta(8),delta(7)-isomerase |
Ki |
15.0 |
nM |
10.1016/j.bmc.2011.10.023 |
| Cavia porcellus |
3-beta-hydroxysteroid-delta(8),delta(7)-isomerase |
Ki |
16.4 |
nM |
10.1021/jm800965b |
| Cavia porcellus |
3-beta-hydroxysteroid-delta(8),delta(7)-isomerase |
Ki |
19.8 |
nM |
10.1021/jm070373b |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
1.02 |
nM |
10.1016/j.bmc.2013.11.014 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
2.0 |
nM |
10.1021/jm800965b |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.bmc.2010.09.026 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.bmc.2014.10.004 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.bmc.2017.12.010 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.bmc.2019.115146 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.bmc.2019.115245 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.ejmech.2017.06.068 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.ejmech.2017.12.054 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.ejmech.2018.08.003 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.ejmech.2018.09.010 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1016/j.ejmech.2020.112138 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1021/acs.jmedchem.2c01003 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1021/acsmedchemlett.9b00524 |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1039/C6MD00621C |
| Cavia porcellus |
Sigma-1 receptor |
Ki |
125.0 |
nM |
10.1039/C8MD00545A |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
450.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
3800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
440.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
890.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ataxin-2 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
12990.0 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
18348.9 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
23000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
281.8 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
326.4 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
2700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
1000.0 |
nM |
10.1021/jm00114a018 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
1200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
1200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
29855.4 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
37585.7 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2A |
Inhibition |
13.08 |
% |
10.1016/j.ejmech.2021.113876 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2A |
Inhibition |
22.27 |
% |
10.1016/j.ejmech.2011.03.013 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2A |
Ratio |
0.77 |
None |
10.1016/j.bmcl.2010.07.043 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
IC50 |
66.0 |
nM |
10.1016/j.ejmech.2011.03.013 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
IC50 |
110.0 |
nM |
10.1016/j.bmcl.2008.04.019 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
IC50 |
177.4 |
nM |
10.1016/j.ejmech.2011.03.013 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
IC50 |
190.0 |
nM |
10.1016/j.bmcl.2010.07.043 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
IC50 |
340.0 |
nM |
10.1016/j.ejmech.2011.03.013 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
IC50 |
340.0 |
nM |
10.1021/jm3015926 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
Inhibition |
0.94 |
% |
10.1016/j.bmcl.2010.07.043 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
Inhibition |
134.75 |
% |
10.1016/j.ejmech.2021.113876 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
Ki |
10.0 |
nM |
10.1016/j.bmc.2010.09.026 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
Ki |
10.0 |
nM |
10.1016/j.ejmech.2018.08.003 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
Ratio |
0.06 |
None |
10.1016/j.bmcl.2010.07.043 |
| Homo sapiens |
Glutamate NMDA receptor; GRIN1/GRIN2B |
Ratio IC50 |
1.0 |
None |
10.1016/j.bmcl.2008.04.019 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 1 |
IC50 |
39500.0 |
nM |
10.1021/acs.jmedchem.7b01640 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
IC50 |
13.3 |
nM |
10.1039/C8MD00545A |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
IC50 |
20.0 |
nM |
10.1016/j.bmc.2013.12.040 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
IC50 |
110.0 |
nM |
10.1021/acs.jmedchem.7b01640 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
Inhibition |
95.0 |
% |
10.1016/j.ejmech.2020.112138 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
10.0 |
nM |
10.1016/j.bmc.2014.10.004 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
10.0 |
nM |
10.1016/j.bmc.2019.115245 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
10.0 |
nM |
10.1016/j.ejmech.2017.12.054 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
10.0 |
nM |
10.1016/j.ejmech.2020.112138 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
10.0 |
nM |
10.1021/acsmedchemlett.9b00524 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
10.0 |
nM |
10.1039/C6MD00621C |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
10.0 |
nM |
10.1039/C8MD00545A |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
10.07 |
nM |
10.1021/acs.jmedchem.2c01003 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 3 |
IC50 |
29100.0 |
nM |
10.1021/acs.jmedchem.7b01640 |
| Homo sapiens |
Glutamate [NMDA] receptor subunit epsilon 4 |
IC50 |
75900.0 |
nM |
10.1021/acs.jmedchem.7b01640 |
| Homo sapiens |
HEK293 |
Potency |
23099.9 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
670.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
100.0 |
nM |
10.1016/j.ejmech.2010.11.042 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
1000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
1000.0 |
nM |
10.1021/jm00114a018 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
631.0 |
nM |
None |
| Homo sapiens |
Ionotropic glutamate receptor NMDA 1/2C |
Inhibition |
28.84 |
% |
10.1016/j.ejmech.2021.113876 |
| Homo sapiens |
Ionotropic glutamate receptor NMDA 1/2D |
Inhibition |
18.09 |
% |
10.1016/j.ejmech.2021.113876 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
1000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Liver microsomes |
T1/2 |
0.08333 |
hr |
10.1016/j.bmc.2010.09.026 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
1000.0 |
nM |
10.1021/jm00114a018 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
2500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
PC-3 |
Activity |
10.0 |
% |
10.1021/jm800965b |
| Homo sapiens |
PC-3 |
Ki |
25.8 |
nM |
10.1021/jm800965b |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
58047.9 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
10399.2 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
11668.1 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
1300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
9600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
2300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
280.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SH-SY5Y |
Activity |
16.4 |
% |
10.1016/j.bmcl.2023.129213 |
| Homo sapiens |
SH-SY5Y |
Activity |
22.57 |
% |
10.1016/j.bmcl.2023.129213 |
| Homo sapiens |
SH-SY5Y |
Activity |
35.81 |
% |
10.1016/j.bmcl.2023.129213 |
| Homo sapiens |
SH-SY5Y |
IC50 |
0.73 |
nM |
10.1021/jm3009458 |
| Homo sapiens |
SH-SY5Y |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
3.9 |
nM |
10.1021/jm00114a018 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Transthyretin |
Activity |
9.1 |
% |
10.1021/acs.jmedchem.1c00823 |
| Homo sapiens |
Transthyretin |
Activity |
27.0 |
% |
10.1021/acs.jmedchem.1c00823 |
| Homo sapiens |
Transthyretin |
Activity |
54.0 |
% |
10.1021/acs.jmedchem.1c00823 |
| Homo sapiens |
Transthyretin |
Activity |
89.0 |
% |
10.1021/acs.jmedchem.1c00823 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
8414.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
21136.0 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
Dopamine D1 receptor |
IC50 |
1000.0 |
nM |
10.1021/jm00114a018 |
| Mus musculus |
Glutamate [NMDA] receptor subunit epsilon 2 |
Activity |
79.0 |
% |
10.1021/jm301508d |
| Mus musculus |
Glutamate [NMDA] receptor subunit epsilon 2 |
Activity |
153.0 |
% |
10.1021/jm301508d |
| Mus musculus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
238.0 |
nM |
10.1021/jm00114a018 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2133.1 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
19011.5 |
nM |
None |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
IC50 |
100.0 |
nM |
10.1021/jm00114a018 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
IC50 |
110.0 |
nM |
10.1021/jm00114a018 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate NMDA receptor |
IC50 |
263.0 |
nM |
10.1021/jm00114a018 |
| Rattus norvegicus |
Glutamate NMDA receptor |
Ki |
143.2 |
nM |
10.1016/j.ejmech.2021.113876 |
| Rattus norvegicus |
Glutamate NMDA receptor; Grin1/Grin2b |
IC50 |
73.0 |
nM |
10.1021/jm8002153 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
IC50 |
20.0 |
nM |
10.1016/j.bmc.2013.12.040 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
IC50 |
20.0 |
nM |
10.1021/jm301508d |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
IC50 |
20.5 |
nM |
10.1016/j.bmc.2008.12.058 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
IC50 |
47.0 |
nM |
10.1016/j.bmc.2016.02.021 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
IC50 |
nan |
None |
10.1016/j.bmc.2013.12.040 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
11.0 |
nM |
10.1016/j.bmcl.2008.04.019 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
19.0 |
nM |
10.1016/j.bmc.2013.11.014 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
20.0 |
nM |
10.1016/j.bmc.2010.08.053 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ki |
29.0 |
nM |
10.1021/jm3009458 |
| Rattus norvegicus |
Glutamate [NMDA] receptor subunit epsilon 2 |
Ratio |
1.0 |
None |
10.1016/j.bmcl.2008.04.019 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Liver microsomes |
T1/2 |
0.01667 |
hr |
10.1016/j.bmc.2010.09.026 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M3 |
IC50 |
1000.0 |
nM |
10.1021/jm00114a018 |
| Rattus norvegicus |
PC-12 |
Activity |
40.3 |
% |
10.1016/j.bmc.2023.117236 |
| Rattus norvegicus |
PC-12 |
Activity |
41.4 |
% |
10.1016/j.bmc.2023.117236 |
| Rattus norvegicus |
PC-12 |
Activity |
46.4 |
% |
10.1016/j.bmc.2023.117236 |
| Rattus norvegicus |
PC-12 |
Activity |
82.3 |
% |
10.1016/j.bmc.2023.117236 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
25574.8 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
1.75 |
None |
10.1016/j.ejmech.2021.113876 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
14.35 |
% |
10.1016/j.ejmech.2021.113876 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1016/j.bmc.2017.12.010 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1016/j.bmc.2019.115146 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1016/j.bmc.2019.115245 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1016/j.ejmech.2017.06.068 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1016/j.ejmech.2017.12.054 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1016/j.ejmech.2018.08.003 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1016/j.ejmech.2018.09.010 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1016/j.ejmech.2020.112138 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1021/acs.jmedchem.2c01003 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1021/acsmedchemlett.9b00524 |
| Rattus norvegicus |
Sigma intracellular receptor 2 |
Ki |
98.0 |
nM |
10.1039/C8MD00545A |
| Rattus norvegicus |
Sigma opioid receptor |
Ki |
2.0 |
nM |
10.1021/jm900366z |
| Rattus norvegicus |
Sigma opioid receptor |
Ki |
4.9 |
nM |
10.1021/jm990277d |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
16360.1 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Activity |
nan |
None |
10.1038/s41586-020-2286-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| None |
ADMET |
T1/2 |
0.08333 |
hr |
10.1016/j.bmc.2010.09.026 |
| None |
ADMET |
TI |
0.38 |
None |
10.1021/jm00114a018 |
| None |
Molecular identity unknown |
Activity |
63.0 |
% |
10.1038/nchembio873 |
| None |
Molecular identity unknown |
Activity |
nan |
None |
10.1038/nchembio873 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1038/nchembio873 |
| None |
NON-PROTEIN TARGET |
EC50 |
206.0 |
nM |
10.1038/nchembio873 |
| None |
NON-PROTEIN TARGET |
EC50 |
420.0 |
nM |
10.1038/nchembio873 |
| None |
NON-PROTEIN TARGET |
EC50 |
1990.0 |
nM |
10.1038/nchembio873 |
| None |
NON-PROTEIN TARGET |
IC50 |
3500.0 |
nM |
10.1021/jm3015926 |
| None |
Unchecked |
Ac50 |
17.78 |
uM |
None |
| None |
Unchecked |
Ac50 |
28.18 |
uM |
None |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
17782.8 |
nM |
None |
| None |
Unchecked |
AC50 |
28183.8 |
nM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
Activity |
65.93 |
% |
10.1016/j.ejmech.2021.113876 |
| None |
Unchecked |
Activity |
76.98 |
% |
10.1016/j.ejmech.2021.113876 |
| None |
Unchecked |
Activity |
85.83 |
% |
10.1016/j.ejmech.2021.113876 |
| None |
Unchecked |
Activity |
nan |
None |
10.1038/nchembio873 |
| None |
Unchecked |
IC50 |
250.0 |
nM |
10.1016/j.bmc.2019.115146 |
| None |
Unchecked |
IC50 |
590.0 |
nM |
10.1016/j.ejmech.2017.12.054 |
| None |
Unchecked |
IC50 |
590.0 |
nM |
10.1016/j.ejmech.2020.112138 |
| None |
Unchecked |
Inhibition |
87.0 |
% |
10.1016/j.ejmech.2017.06.068 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2018.09.006 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Ki |
2.3 |
nM |
10.1021/jm800965b |
| None |
Unchecked |
Ki |
10.0 |
nM |
10.1016/j.bmc.2017.12.010 |
| None |
Unchecked |
Ki |
10.0 |
nM |
10.1016/j.bmc.2019.115146 |
| None |
Unchecked |
Ki |
10.0 |
nM |
10.1016/j.ejmech.2017.06.068 |
| None |
Unchecked |
Ki |
10.0 |
nM |
10.1016/j.ejmech.2018.09.010 |
| None |
Unchecked |
Ki |
18.8 |
nM |
10.1016/j.bmc.2013.11.014 |
| None |
Unchecked |
Ki |
98.0 |
nM |
10.1039/C6MD00621C |
| None |
Unchecked |
Ki |
98.3 |
nM |
10.1016/j.bmc.2010.09.026 |
| None |
Unchecked |
Ki |
98.3 |
nM |
10.1016/j.bmc.2014.10.004 |
| None |
Unchecked |
Ki |
3080.0 |
nM |
10.1021/jm3009458 |
| None |
Unchecked |
Ki |
10000.0 |
nM |
10.1016/j.ejmech.2017.06.068 |
| None |
Unchecked |
Ki |
nan |
None |
10.1039/C6MD00621C |
| None |
Unchecked |
Potency |
2818.4 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Potency |
20587.8 |
nM |
None |
| None |
Unchecked |
Potency |
29092.9 |
nM |
None |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |
| None |
Unchecked |
Potency |
36125.4 |
nM |
None |
| None |
Unchecked |
Ratio |
0.87 |
None |
10.1016/j.bmcl.2010.07.043 |
| None |
Unchecked |
Ratio IC50 |
200.0 |
None |
10.1021/jm3015926 |
| None |
Unchecked |
Ratio Ki |
0.05 |
None |
10.1016/j.bmc.2013.11.014 |
| None |
Unchecked |
Ratio Ki |
0.12 |
None |
10.1021/jm800965b |
| None |
Unchecked |
Ratio Ki |
0.14 |
None |
10.1021/jm800965b |
| None |
Unchecked |
Ratio Ki |
0.8 |
None |
10.1016/j.ejmech.2018.09.010 |
| None |
Unchecked |
Ratio Ki |
1.27 |
None |
10.1021/acs.jmedchem.2c01003 |
| None |
Unchecked |
Ratio Ki |
10.0 |
None |
10.1016/j.ejmech.2017.06.068 |
| None |
Unchecked |
Ratio Ki |
13.0 |
None |
10.1016/j.ejmech.2017.06.068 |